Abstract：
This is a Brighton Collaboration case definition of anosmia to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by two expert reviewers prior to submission.
摘要：
这是BrightonCollaboration的病例定义，用于评估免疫接种后的不良事件。以及用于评估背景发病率或假设检验的流行病学研究。病例定义是由流行病防备创新联盟（CEPI）召集的专家组在积极开发SARS-CoV-2疫苗的背景下制定的。遵循布莱顿合作组织的案例定义格式，以制定共识定义和确定水平，经过详尽的文献回顾和专家咨询。该文件在提交之前经过了布莱顿合作网络和两名专家审稿人的同行评审。
